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The identification of specific genetic loci that contrib-
ute to inflammatory and autoimmune diseases has
proved difficult due to the contribution of multiple in-
teracting genes, the inherent genetic heterogeneity
present in human populations, and a lack of new
mouse mutants. By using N-ethyl-N-nitrosourea (ENU)
mutagenesis to discover new immune regulators, we
identified a point mutation in the murine phospholi-
pase Cg2 (Plcg2) gene that leads to severe spontane-
ous inflammation and autoimmunity. The disease is
composed of an autoimmune component mediated by
autoantibody immune complexes and B and T cell in-
dependent inflammation. The underlying mechanism
is a gain-of-function mutation in Plcg2, which leads
to hyperreactive external calcium entry in B cells and
expansion of innate inflammatory cells. This mutant
identifies Plcg2 as a key regulator in an autoimmune
and inflammatory disease mediated by B cells and
non-B, non-T haematopoietic cells and emphasizes
that by distinct genetic modulation, a single point mu-
tation can lead to a complex immunological phe-
notype.
Introduction
Spontaneous inflammation and autoimmunity occur to-
gether in diseases such as systemic lupus erythema-
tosus (SLE), rheumatoid arthritis, and Wegener’s granu-
lomatosis (WG) (Sack and Fye, 2001). Indeed, the
association is so tight that it is not known whether an
unrestrained inflammatory response or an inappropri-
ate autoimmune response to self-antigen or both initi-
ate the diseases. Molecular mechanisms involved are
further obscured by the complex genetics underlying
this group of diseases that make identification of key
regulatory genes difficult (Roberton and Vyse, 2000;
Ueda et al., 2003; Wollheim et al., 2003).
To identify genetic alterations in genes involved in au-
toimmunity or inflammation, we employed large-scale
ENU mutagenesis in the mouse together with clinical
screening for relevant phenotypes. Mice with profound
immunological alterations were identified, and posi-
tional cloning of the mutations was performed (Hrabe
de Angelis et al., 2000; Nelms and Goodnow, 2001). The10 Present address: Roche Diagnostics GmbH, Nonnenwald 2,
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452advantage of this forward genetics approach is the im- b
mediate association of gene and phenotype without c
previous assumptions about physiological gene func- t
tion. Importantly, this strategy allows the identification t
of hypermorphic mutations, resulting in insights that e
could not be readily obtained with the conventional e
backward genetics approach, i.e. gene knockout, now v
dominantly employed in mouse genetics (Nathan, f
2002). o
From a genetic point of view, it is important to note m
that all human autoimmune inflammatory diseases
seem to be multigenic, whereas evidence for complex m
genetic interactions has been presented for only two h
out of 40 gene knockout models of inflammation (Na- a
than, 2002). Only the IL-1Rα and FcγRIIb loss-of-func- o
tion phenotypes are modulated in different genetic B
backgrounds (Bolland and Ravetch, 2000; Horai et al., a
2000), making them more relevant models for human m
diseases. n
Like other signaling molecules, PLCG2 seems to be s
integrated into the complex regulation of the immune o
system. It is a member of the phosphoinositide-specific
phospholipase C (PI-PLC) family, is highly expressed, R
and is required for function of haematopoietic cells, in-
cluding B cells, NK cells, mast cells, macrophages, and D
platelets (Hiller and Sundler, 2002; Kurosaki et al., 2000; o
Wang et al., 2000; Wen et al., 2002). In T cells, however, F
the other member of the PLCγ subfamily, PLCγ1, has a o
major functional role. Despite the recognition of the PI- A
PLC family as key enzymes in signal transduction for d
nearly three decades (Rhee, 2001), the complex regula- f
tory mechanisms of PLCγ isoforms have been appreci- p
ated only recently (Patterson et al., 2002; Ye et al., B
2002). Generally, PLCγ isoforms are localized in the (
cytoplasm but are recruited to the membrane upon re- d
ceptor activation where further protein-protein and pro-
w
tein-lipid interactions, together with tyrosine phosphor-
f
ylation, contribute to their activation. For PLCγ2, such
d
a signaling mechanism is best defined in B cell re-
asponses (Kurosaki et al., 2000; Marshall et al., 2000).
sBriefly, the stimulation of the B cell receptor (BCR) and
other receptors regulates PLCγ2 through a set of pro-
Ptein tyrosine kinases (Lyn, Syk, and Btk) and inositol-
vlipid-kinases (PI-3K) that generally contribute to acti-
ivation, whereas phosphatases acting on the same
gsubstrates (tyrosine phosphatase SHP-1 and inositol-
ulipid phosphatase SHIP) have an inhibitory impact
m(Coggeshall et al., 2002). Membrane interactions of the
tassembled BCR signalosome are stabilized by pro-
pduction of phosphatidylinositol 3,4,5-trisphosphate
g(PIP3) that binds to pleckstrin homology (PH) domains
aof Btk and PLCγ2 itself. The catalytic domain of PLCγ2
malso has to interact with the membrane to access and
ahydrolyze the substrate phosphatidylinositol 4,5-bis-
lphosphate (PIP2) to generate diacylglycerol (DAG) and
inositol 1,4,5-trisphosphate (IP3) (Hurley and Grobler,
F1997). In immune cells, as in other cell types, the pro-
nduction of these secondary messengers leads to acti-
cvation of DAG targets (e.g., protein kinase C) and an
oincrease in intracellular Ca2+, which has been recog-
lnized as crucial in mediating a variety of cellular re-
Psponses (Rhee, 2001; Wilde and Watson, 2001). The
mtight connection between PLCγ activity and Ca2+ in-
crease in the cytoplasm has recently been emphasized iy the discovery of a novel mechanism by which PLCγ
an mediate external Ca2+ entry independent of its ca-
alytic activity, probably through protein-protein in-
eractions (Patterson et al., 2002; Putney, 2002; Putney
t al., 2001; van Rossum et al., 2005). Despite the
xtensive experimental evidence supporting that acti-
ation of PLCγ and, particularly, the downstream Ca2+
lux are important signaling events in cellular activation
r apoptosis, relatively limited advances have been
ade to assess its potential role in disease.
Here, we identify and characterize a gain-of–function
utation in Plcg2 and show the consequences of en-
anced Plcγ2 signaling in vivo. On the cellular level,
ugmented external Ca2+ entry is shown. Deregulation
f different components of the immune system, namely
cells and cells of the innate immune system, underlie
utoimmune and inflammatory symptoms in mutant
ouse strains. Crossing of the mice to a different ge-
etic background and to lymphocyte-deficient mice
uggest different independent mechanisms of pathol-
gy induced by the Plcg2 mutation.
esults
ifferential Pathology of Plcg2Ali5 Mice Depends
n Genetic Background and Gene Dosage Effects
rom a single female of the first generation of offspring
f ENU-treated C3HeB/FeJ (C3H) mice, the mouse line
li5 (Abnormal limb 5) was established on the basis of
ominant inheritance of spontaneous swollen and in-
lamed paws. In addition, 50% of the offspring dis-
layed an abnormally high ratio of T cells versus mature
cells (Figure 2A). Maintaining the line on a wild-type
wt) C3H background for more than ten generations
emonstrated that the inheritance of the phenotype
as autosomal dominant and coincided with male in-
ertility (P.Y., N.D., U.H., S.K., L.Q.-M., unpublished
ata). In C3H mice, the penetrance was 100% for the
bnormal T:B cell ratio but only 60%–80% for the
wollen paw phenotype.
The nonconservative amino acid exchange in
lcγ2Ali5 results in severe and complex pathology in
ivo (Figures 1A–1U and overview in Table 1). C3H-
nbred Plcg2Ali5/+ mice have normal paws at birth but
radually develop swollen and deformed footpads (Fig-
res 1A–1F). Male mice were affected earlier than fe-
ale mice (2 months cf. 8–10 months). Initially, dermati-
is developed in the superficial layers of the skin of the
aws and ears (Figures 1E–1H). The infiltrate included
ranulocytes, macrophages, lymphocytes, mast cells,
nd eosinophils (data not shown). This chronic inflam-
ation gradually affected the bone, resulting in severe
rthritis of the small joints of the paws and missing pha-
anges (Figures 1C–1F).
In contrast, the heterozygous C57BL/6J × C3HeB/
eJ (B6C3) mice (N2 and N3 backcross generation) had
o inflammation, neither macroscopically nor histologi-
ally (Figure 1I and data not shown). However, three out
f ten hybrid Plcg2Ali5/+ mice showed signs of glomeru-
onephritis (see below). Intercrossing of the N1 or N2
lcg2Ali5/+ mice yielded offspring homozygous for the
utation. w90% of homozygotes suffered from severe
nflammation of the paws, but unlike heterozygous C3H
Mutant Plcγ2 Causes Autoimmunity and Inflammation
453Figure 1. Pathology of Ali5 Mice
(A–H) Inbred C3H background. (A) Paw of a wild-type (wt) mouse (aged 62 days). (B) Swollen paw of a Plcg2+/Ali5 littermate. (C) Radiography
of a paw of a wt mouse (aged 405 days). (D) Plcg2+/Ali5-affected littermate show bone destruction and loss of bone density, enlarged soft
tissue shadow, and exostosis around the interphalangeal joints. (E) Histological analysis of the phalanges. HE staining of middle and distal
phalanx of control animal (aged 405 days, 40×). (F) Inflamed phalanx of a Plcg2+/Ali5 mouse (aged 73 days). (G) HE staining of the ear of a wt
mouse (aged 90 days). (H) Ear of the Plcg2Ali5/+ littermate (100×; arrow shows circumscriptive infiltration).
(I–U) Hybrid B6C3 Plcg2Ali5/+ and Plcg2Ali5/Ali5 mice. (I) Radiographs of paw of a Plcg2Ali5/+ mouse (aged 77 days) showing no alterations. (J)
Plcg2Ali5/Ali5 littermates show similar paw phenotype to inbred Plcg2Ali5/+ mice (see [D]). (K) Histology of the kidney (PAS stain, 400×) shows a
normal glomerulum of a Plcg2Ali5/+ mouse. (L) Plcg2Ali5/Ali5 mice with intracapillary and extracapillary proliferative glomerulonephritis. (M)
Electron microscopy of a normal kidney (Abbreviations: FP, foot processes of the podocytes; BM, base membrane; END, endothelium). (N) A
Plcg2Ali5/Ali5 mouse showing fusion of FP and electron dense deposits (EDD) in the subepithelial region (SR) of the BA. (O) Plcg2Ali5/+ mouse
(right) with normal eyes and paws (arrow 2) and a Plcg2Ali5/Ali5 littermate (left) with eye deformations and crippled paws (arrow 1). (P) Compari-
son of a normal eye of a heterozygous mouse and (Q) an affected eye of a Plcg2Ali5/Ali5 mouse, which shows proliferation of cells in the
epithelium (arrow 4) and thinning of the sclera (arrow 3). (R and T) The Plcg2Ali5/+ mouse has a normal structure of the cornea (40×, 160×). (S)
HE section of a Plcg2Ali5/Ali5 mouse with keratitis (40×). (U) Higher magnification shows destruction of the different layers of the corneal
epithelium with keratinization (160×). The inflammatory infiltrate is composed of neutrophil granulocytes, eosinophils and lymphocytes (in-
sert, 640×).mice, they developed severe keratitis (nine out of ten
mice) and proliferative intra- and extracapillary glomer-
ulonephritis (eight out of eight mice; Figures 1K–1N and
1O–1U). The different phenotypes arising from the vari-
ous combinations between genetic background and
gene dosage of the mutant allele suggest that genetic
modifiers modulate the penetrance and the quality of
the Plcg2Ali5-induced pathology.
Identification of Mutant Plcg2Ali5
by Positional Cloning
Mice that carry the Plcg2Ali5 allele in a hybrid B6C3
background displayed no paw abnormalities and
showed a reduced but nevertheless elevated ratio of T
cells versus mature B cells (Table 1 and Figure 2A). This
altered ratio was fully penetrant and therefore used as
a marker for positional cloning purposes. Genetic map-
ping narrowed the mutation to a 1.3 Mb region on chro-
mosome 8 (Figures 2B and 2C). Sequencing of all exons
of all five genes in this region identified a single A-G
exchange in exon 27 of the Plcg2 gene (Figure 2D). Themutation was present in all affected mice (n > 300). The
mutation results in a single amino acid substitution of
aspartic acid with glycine at position 993 (D993G). This
aspartic acid is conserved in all PLC isoforms (Figure
2E). We have named this allele Plcg2Ali5. The mutation
was maintained in a C3H background by breeding het-
erozygous Plcg2Ali5/+ mice to wt C3H animals for more
than ten generations, such that statistically 99.9% of
the genome of the original F1 founder genome has
been replaced. During this process, the original pheno-
type was stable and the phenotype strictly segregates
with the Plcg2 genotype in all affected mice tested
(>300).
The aspartic acid residue mutated in Plcγ2Ali5 is lo-
cated within the region of the catalytic domain de-
scribed as a “ridge” surrounding the active site opening
of Plcγ2 that has been suggested to exert an inhibitory
impact on PLC activity by preventing extensive mem-
brane interactions (Ellis et al., 1998) (Figure 3A). It is
interesting to note that the inside of eukaryotic plasma
membranes is negatively charged. So the loss of a
Immunity
454Table 1. Phenotype Overview
C3HeB/FeJ C3HeB/FeJ x C57BL/6J
Genotype Plcg2+/Ali5 Plcg2+/+ Plcg2Ali5/Ali5 Plcg2+/Ali5 Plcg2+/+
Phenotype
Ratio T cell/mat. B2 cella 13.5 1.3 5.2 3 2.1
Paw inflammation Yes No Yes No No
Autoantibodies No No Yes (66%) Yes (28%) No
Glomerulonephritis No No Yes (100%)b Yes (30%)c No
Growth retardation No No Yes No No
Keratitis No No Yes No No
Summary of phenotypes using Ali5 and littermate controls in C3HeB/FeJ and hybrid C3HeB/FeJ × C57BL/6J N2 or N3 genetic background.
a In peripheral blood.
b Eight out of eight tested.
c Three out of ten tested.negative charge by the D993G mutation in this impor- s
ntant region of the molecule might reduce repulsion of
Plcγ2Ali5 from the membrane. t
p
iThe Point Mutation in Plcg2Ali5 Is Likely to Increase
athe Extent of Membrane Interactions Rather
than the Properties of the Phospholipase Active Site
iTo assess Plcg2Ali5 function in a signaling context, we
ifocused on well-characterized responses of B cells. In
mpurified B cells from C3H Plcg2Ali5/+ mice, normal
cPlcg2Ali5 mRNA expression was detected (Figure 3B).
pHowever, moderately reduced expression of Plcg2Ali5
lprotein was seen in both C3H and C3B6 mice (Fig-
ure 3C).
Our initial data using DNA arrays to analyze purified P
CB cells from Plcg2Ali5/+ C3H mice and wt littermates re-
vealed differences in gene expression (data not shown). T
tInterestingly, the upregulated mRNAs included those
for S100a9 and S100a6, but not Plcγ2, Igα, and Map2K P
I(Figure 3B). The S100 family of molecules is believed
to function through direct calcium binding and is also r
limplied in inflammation (Roth et al., 2003; Ryckman et
al., 2003); this further supports the importance and s
rcomplexity of changes in calcium responses.
Analysis of Plcγ2 basal activity using purified recom- i
obinant protein in mixed micelles in vitro, bypassing
requirements for membrane interactions, showed a o
hslightly, but not significantly, elevated activity of the
mutant (Figure 3D). This is consistent with the position b
aof this mutation at the membrane interaction surface
and previous findings that mutations within this region d
Fin PLCδ1 affected PLC function by increasing mem-
brane interactions rather than changing properties of t
Cthe active site.
To examine this further, we performed membrane lo- u
mcalization studies of wt and mutant Plcγ2 expressed in
the WEHI-231 B cell line. Before stimulation, neither wt p
nor mutant Plcγ2 can be detected at the cytoplasmic
membrane. Addition of anti-IgM Ab induces the recruit- r
tment of Plcγ2 to the membrane in comparable
amounts. However, at later timepoints (15 min), this re- c
scruitment is noticeably more prominent for Plcγ2Ali5
(Figure 3E). Because the hydrophobic ridge is one of i
sseveral domains (e.g., PH and SH2 domains) that con-
tribute to membrane interactions, its importance in reg- c
2ulating Plcγ2 functions can be exerted earlier throughubtle changes in the enzyme positioning, which could
ot be simply assessed by monitoring membrane in-
eractions. It is, however, possible that at later time
oints, in the absence of other interactions, mutations
n the hydrophobic ridge prolong membrane associ-
tion.
In summary, these results imply that the Ali5 mutation
n Plcg2 does not result in an overexpression of Plcg2
n vivo and has no effect on basal phospholipase enzy-
atic activity of Plcγ2 in vitro, rather, the mutation
hanges its ability to interact and remain at the cyto-
lasmic membrane. This in turn may enhance or pro-
ong its activity postactivation.
lc2Ali5 Induces Increased and Sustained External
alcium Entry in B Cells
o examine Ca2+ mobilization after anti-IgM stimula-
ion, we first confirmed that B cells from inbred C3H
lcg2+/Ali5 and Plcg2+/+ mice had comparable levels of
gM surface expression (Figure 4A). Plcg2+/Ali5 B cells
esponded with a higher initial peak and sustained Ca2+
evels when a complete anti-IgM antibody was used to
timulate the BCR (Figure 4A, 1 versus 2). This Ca2+
esponse in Ali5 is similar to responses in B cells lack-
ng inhibitory signals normally generated by coligation
f FcγRIIb (Ravetch and Bolland, 2001). The absence
f SHIP activation under such circumstances results in
igher PIP3 levels, which stabilize Btk and Plcγ2 mem-
rane interactions, resulting in sustained IP3 production
nd Ca2+ responses (Scharenberg and Kinet, 1998). In-
eed, the removal of this inhibitory signal using a
(ab#)2-anti-IgM fragment reduced differences between
he mutant and wt Plcγ2 protein, but a higher sustained
a2+ response was still observed in mutant B cells (Fig-
re 4A, 3 versus 4). This suggests that the Ali5 mutation
ight contribute to stabilization of membrane com-
lexes, thus substituting for PIP3 binding.
To confirm that the changes in Ca2+ signaling are the
esult of the mutation in Plcg2, the wt and mutant pro-
eins were expressed in primary LPS-activated wt B
ells by retroviral transfection of Plcg2 cDNA expres-
ion constructs. Both the wt and mutant Plcγ2 proteins
nduced an elevated Ca2+ baseline and stronger Ca2+
ignal upon anti-IgM stimulation (Figure 4B, 3 and 4)
ompared to the endogenous Plcg2 (Figure 3B, 1 and
). Expression of Plcg2Ali5 in the B cells resulted in
Mutant Plcγ2 Causes Autoimmunity and Inflammation
455Figure 2. Identification of a Point Mutation in Plcg2 in Ali5 Mice
(A) Flow cytometric analysis of peripheral blood of Ali5 mice. Num-
bers indicate the percentage of gated populations of T cell (anti-
CD3) versus mature B2 cell (anti-CD23) lymphocyte populations in
peripheral blood. This staining was used as the phenotypic screen
for the positional cloning.
(B) Identification of a point mutation in the Plcg2 gene. One step
chromosomal mapping by determination of the SNP allele fre-
quency of unaffected mice of the Ali5 line. w90 SNPs polymorphic
between C3HeB/FeJ and C57BL/6J strains, which are equally dis-
tributed over the 19 autosomal mouse chromosomes, were used,.
SNP allele frequency was measured by using Pyrosequencing
technology. The Ali5-negative DNA pool analysis showed increased
proportions of BL/6 alleles on chromosome 8. Statistically, one ex-
pects an average BL/6 to C3H ratio of 3 at an unlinked marker in
N2 animals. The ratio is much higher (maximum of 13) on chromo-
some 8.
(C) Fine mapping using informative Ali5 mice. The proximal border
is defined by flanking marker D8Ing65 of mouse ID 377, whereas
the distal flanking marker DIng60 is informative in three mice: 404,
317, and 433. The position of the two internal and two flanking
marker is given in Mb with respect to the mouse genome assem-
bly MGSCv3.
(D) Sequence of murine Plcg2 from wt, heterozygous Plcg2Ali5/+ (Ali5
het.), and homozygous Plcg2Ali5/Ali5 mice (Ali5 hom.) revealed an
A/G mutation in Ali5. The figure shows the sequence chromato-
gram from exon 27 around the mutation site. Where C3H and BL/6
carry an A at the respective position, Ali5 heterozygous mice show
a G/A double peak, and Ali5 homozygous mice carry only a G.
(E) A multiple sequence alignment of part of the Y catalytic domain
of different PLC protein family members from three different spe-
cies (mouse, rat, and human) showing the high level of conserva-
tion between the three species and the location of the mutation
(arrow at the D for aspartic acid).downregulation of IgM surface expression in vitro (Fig-
ure 4B). Nevertheless, cells with Plcg2Ali5 responded to
F(ab#)2-anti IgM with a more sustained Ca2+ elevation
than those with wt Plcg2 (Figure 4B, 3 and 4). This sug-
gests that Plcγ2Ali5 activity underlies the changes in
Ca2+ responses.
In order to further examine the pathway of Ca2+ in-
flux, we withdrew exogenous Ca2+ and added EGTA.
This led to a complete inhibition of the increased Ca2+
response (Figure 3C, compare 1 and 2 in the top panel
with 1 and 2 in the bottom panel), suggesting that the
Ca2+ efflux from the internal stores to the cytoplasm is
not affected by the D993G mutation, whereas the
plasma membrane channel-mediated Ca2+ entry from
the outside is dramatically elevated (Figures 4C–4E).
Thapsigargin-mediated depletion of internal Ca2+
stores and the increase of cytoplasmic Ca2+ lead to
opening of external Ca2+ plasma channels, by an un-
known mechanism, independent of Plcγ2 function (Put-
ney, 2002; Putney et al., 2001). Both internal and exter-
nal thapsigargin-activated Ca2+ fluxes were not altered
in Ali5 B cells (Figure 4C, compare 3 and 4 in the top
panel with 3 and 4 in the bottom panel). This proves
that changes in external Ca2+ entry are dependent on
physiological BCR activation of Plcγ2, but not by a
mere increase of the cytoplasmic Ca2+ concentration.
Heterozygous Ali5 B cells on a hybrid B6C3 back-
ground respond similarly to mutant C3H B cells (Figure
4C) after BCR and thapsigargin stimulation (Figures 4D
and 4E).
We also compared the Ca2+ flux of B cells from wt,
heterozygous, and homozygous Plcg2Ali5 mice by using
the Ca2+ fluorophore Indo-1, which is less prone to
loading artefacts. Stimulation with complete anti-IgM
leads to enhanced and sustained cytoplasmic Ca2+
concentrations in both heterozygous and homozygous
B cells (Figure 4E). In cells from wt mice, this response
could be completely inhibited by the addition of 0.2 M
of the phospholipase C inhibitor U73122 (Figure 4E,
top, 4 and 5) (Taylor and Broad, 1998). However, it is
notable that while being strongly inhibited, mutant cells
still displayed a low but detectable Ca2+ increase (Fig-
ure 4E, bottom).
In contrast to changes in B cell calcium responses,
Ali5 T cells did not show an enhanced Ca2+ response
after TCR stimulation (Figure 4A, 5 and 6). This is in
line with a predominant expression of Plcg1 rather than
Plcg2 in these cells.
In addition to changes in calcium concentrations, the
production of IP3 was also monitored and found to be
increased in both B cells from Ali5 mice and WEHI-231
cells expressing mutated Plcg2. For WEHI/Plcg2wt, the
basal level was 1.5 ± 0. 1 (pmol/assay) and increased
after stimulation with IgM to 1.8 ± 0.2 after 30 s and to
2.2 ± 0.2 after 60 s. For WEHI/Plcg2Ali5, the basal level
was 1.5 ± 0.1 and increased after stimulation to 3.1 ±
0.4 after 30 s and to 4.2 ± 0.4 after 60 s. IP3 returned to
the basal level after 240 s. In B cells from the wt mice,
the basal level was 0.19 ± 0.03 and increased after
stimulation with IgM to 2.3 ± 0.2 after 30 s and to 6.2 ±
0.5 after 60 s. For Ali5 mice, the basal level was 0.2 ±
0.03 and increased after stimulation with IgM to
2.6 ± 0.1 after 30 s and to 10.1 ± 0.7 after 60 s.
Taken together, these results imply that the Ali5 mu-
Immunity
456Figure 3. The Plcγ2Ali5 Mutation, Plcg2 Ex-
pression, In Vitro Enzymatic Activity of Mu-
tant Plcγ2, and Membrane Localization of
Mutant Plcγ2
(A) Domain structure of Plcγ2 and ribbon dia-
gram model on the basis of the rat Plcδ1
crystal structure (Essen et al., 1996) of the
catalytic domains (X and Y) of murine Plcγ2.
The three loops that surround the active cen-
ter, which contains the substrate (green), ex-
tend toward the inner side of the cytoplas-
mic membrane. They form a ridge that points
toward the membrane. The position of the
asp993 to gly993 mutation is depicted by the
spheres (arrow). Abbreviations: PH, pleck-
strin homology domain; EF, EF-hand domain;
SH2/SH3, src homology domain 2 and 3; and
C2, C2 domain.
(B) Quantitative PCR analysis of Plcg2 ex-
pression in purified B cells from inbred het-
erozygous Plcg2Ali5/+ C3H mice and wt litter-
mates. Plcg2 and two control genes (Iga and
Map2k) were expressed at normal levels,
and the genes S100a9 and S100a6, pre-
viously identified as dysregulated in a DNA
chip experiment (data not shown), were con-
firmed as upregulated.
(C) Plcγ2 protein expression in purified B
cells from hybrid B6C3 and C3H Plcg2Ali5/+
mice. Plcγ2-specific Western blot (top) and
actin-loading control (bottom) are shown.
(D) Enzymatic activity of recombinant Plcγ2
enzyme. The wt Plcγ2 (1) and Plcγ2Ali5 (2)
were purified (left) and subsequently used
for determination of basal-specific activity
toward PIP2 substrate in a micelle in vitro
system (right). Km values obtained by using
the same assay were 129 ± 14 M for the wt
and 131 ± 10 M for the Ali5 mutant. Error
bars represent the mean ± SD.
(E) Membrane localization of Plcγ2 after anti-
IgM stimulation. WEHI-231 cells transfected
with retrovirale vectors containing wt (dark
bars) and mutant Plcγ2 (light bars) were stim-
ulated, and the membrane localized Plcγ2 was detected by Western blot. Caveolin-1 and total Plcγ2 are shown as membrane fraction and
protein expression controls, respectively. Error bars represent the mean ± SD.tation in Plcg2 represents a gain-of-function hypermor- p
Pphic mutation that is active in vivo. It induces a higher
aand sustained Ca2+ flux into the cytoplasm, probably
pby influencing the external Ca2+ entry through plasma
tmembrane channels in response to BCR activation.
u
P
Expansion of Innate Immune Cells in the Bone f
Marrow of Plcg2Ali5 Mice and Disease Transfer h
via Bone Marrow Transplantation c
Both inflammatory cells of the innate and the cells of i
the adaptive immune system arise from bone marrow a
and share similar signaling pathways that require the t
presence of Plcγ2 (Bourette et al., 1997; Wang et al., u
2000). Because histology of the affected organs
showed increased numbers of granulocytes in in- l
filtrates, we analyzed cells of the bone marrow where r
granulocytes arise. We identified similar total numbers a
of bone marrow cells in mutant and wt mice (wt-B6C3 = f
2.9 × 107, n = 4; Plcg2Ali5/+ B6C3 = 3.1 × 107, n = 4; h
Plcg2Ali5/Ali5 B6C3 = 2.7 × 107, n = 3; wt-C3 = 1.7 × 107, s
n = 4; and Plcg2Ali5/+ C3H = 1.8 × 107, n = 4). However, t
an increased ratio of granulocyte/macrophage to lym-hocyte precursors was observed in Ali5 mice. The
lcg2Ali5/Ali5 B6C3 hybrid mice had a 10-fold increase
nd inbred C3H Plcg2Ali5/+ mice a 2-fold increase com-
ared to Plcg2+/+ littermates (Figure 5A). Additionally,
he Gr1low/CD11b-positive macrophage precursor pop-
lation was increased by about 50% in inbred
lcg2+/Ali5 and Plcg2Ali5/Ali5 mice (Figure 5A). In order to
urther examine the role of bone marrow-derived
aematopoietic cells, we transplanted bone marrow
ells from a severely affected B6C3 Plcg2Ali5/Ali5 mouse
nto wt mice. Two out of ten mice developed swollen
nd inflamed paws 4 weeks after the transfer, indicating
hat haematopoietic cells can transfer the disease (Fig-
re 5B).
To answer the question about whether transferred
ymphocytes develop normally, we analyzed the ratio of
epopulating B versus T cells. Upon transfer to irradi-
ted wt recipients, the ratio of B cells to T cells was four
or wt (n = 2), but consistently below one for transfer of
omoyzgous Ali5 bone marrow (n = 9). This demon-
trates that the reduced B cell number is an effect in-
rinsic to cells derived from transferred bone marrow.Whether the effect is intrinsic to B cells or dependent
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457Figure 4. Ca2+ Mobilization in B Cells
(A) Ex vivo B cell stimulation of cells from inbred C3H Plcg2Ali5/+ and
wt littermates. Histograms show IgM expression of purified B cells
(values are mean fluorescence). Spleen cells were loaded with
Fluo-3 and stimulated by anti-IgM (either complete anti-IgM or the
anti-IgM F(ab#)2 fragment) or anti-TCR Ab, and the fluorescence
was measured by flow cytometry in relative fluorescence units (rfu).
Ali5 B cells, complete Ab (1); wt B cells, complete Ab (2); Ali5 B
cells, F(ab#)2 (3); wt B cells, F(ab#)2 (4); wt T cells, anti-TCR (5); and
Ali5 T cells, anti-TCR (6).
(B) In vitro Ca2+ mobilization in primary B cells infected with wt and
mutant Plcg2 in MIGR1 retroviral vectors (which also contain IRES-
GFP). Histograms show IgM expression of cells. Cells were loaded
with Fura-Red, counterstained with B220, and stimulated with anti-
IgM F(ab#)2. GFP-negative cells are not transfected by the GFP-
containing retrovirus and serve as negative control (1,2). Note that
Fura-Red has an inverse correlation to Ca2+ concentration, as
higher Ca2+ results in lower fluorescence emission. MIGR1Ali5-
GFPnegative (1); MIGR1WT-GFPnegative (2); MIGR1WT-GFPpositive (3);
and MIGR1Ali5-GFPpositive (4).
(C) Internal and external Ca2+ flux in primary B cells. Ex vivo B cell
stimulation of cells from inbred C3H Plcg2Ali5/+ mice or wt litter-
mates by anti-IgM-F(ab#)2 and thapsigargin. Spleen cells were
loaded with Fluo-3 as described and activated in Ca2+ containing
buffer (top) or without Ca2+ but containing EGTA (bottom). Ali5 B
cells, F(ab#)2 (1); wt B cells, F(ab#)2 (2); Ali5 B cells, thapsigargin (3);
and wt B cells, thapsigargin (4).
(D) Ca2+ influx in primary B cells from hybrid B6C3 heterozygous
Plcg2+/Ali5 and wt littermates by anti-IgM-F(ab#)2 and thapsigargin.
Spleen cells were loaded with Fluo-3 as described and activated in
Ca2+ containing buffer. Ali5 B cells, F(ab#)2 (1); wt B cells, F(ab#)2
(2); Ali5 B cells, thapsigargin (3); and wt B cells, thapsigargin (4).
(E) Indo-1 Ca2+ measurement and U73122 Plc inhibition in primary
B cells from hybrid B6C3. B cells from heterozygous Plcg2+/Ali5 (1)
and homozygous Plcg2Ali5/Ali5 (2), and wt mice were stimulated by
anti-IgM (3). Spleen cells were loaded with Indo-1 as described
and activated in Ca2+ containing buffer. 0.2 M U73122 Plc inhib-
itor was added to heterozygous Plcg2+/Ali5 (4), homozygous
Plcg2Ali5/Ali5 (5), and wt cells (6). Bottom panel shows a magnifica-
tion of Ca2+ signal with U73122 inhibitor. Values are the ratio of
signal from Ca2+ bound Indo1 (F6) to free Indo-1 (F7).on interactions with other cells derived from bone mar-
row, e.g. macrophages, would need to be addressed
with mixed bone marrow chimeras as in SHP-1 deficient
mice (Cyster and Goodnow, 1995).
As an increased absolute number of granulocytes
and macrophages alone would not appear to explain
the disease in Plcg2Ali5 mice, we investigated whether
functional differences occur in granulocytes, macro-
phages, or dendritic cells (DCs). Granulocytes from the
peritoneal cavity of C3H Plcg2Ali5/+ and wt controls
exhibit similar phagocytosis of fluorescence-labeled
E. coli (data not shown). Bone marrow-derived macro-
phages and DCs were stimulated with various toll-like
receptor ligands, e.g. LPS, R-848, poly I:C, and CpG
oligo-DNA (Beutler et al., 2003), but no differences in
inflammatory cytokine production or upregulation of
activation markers were observed (data not shown). In
addition, a model of abdominal sepsis (colon ascen-
dens stent peritonitis) (Zantl et al., 1998) and TNCB-
mediated contact dermatitis-induced skin inflammation
resulted in responses similar to wt mice both in and ex
vivo (data not shown). On the other hand, the stimula-
tion of Gr1-positive granulocytes from peripheral blood
of C3H Ali5 mice via the FcγR results in sustained Ca2+
mobilization similar to that observed in B cells (Fig-
ure 5C).
These results confirm a role of Plcγ2 signals in expan-
sion of inflammatory cells but make it unlikely that toll-
like receptor-mediated inflammatory pathways are in-
volved in targeting of the inflammatory reaction. Transfer
of bone marrow from a homozygous Plcg2Ali5/Ali5 mouse,
which contains few lymphocytes but high numbers of
granulocyte-macrophage precursors, leads to induc-
tion of paw-specific inflammation.
Lymphocyte-Independent Arthritis and Dermatitis
in C3HeB/FeJ Plcg2Ali5/+ Mice
In order to resolve the specific contribution of lympho-
cytes and non-B, non-T cells to the induction of
the paw-specific arthritis and dermatitis, we mated
Plcg2Ali5/+ heterozygous mice on the C3H genetic back-
ground with Rag1-deficient mice lacking B and T cells
(Mombaerts et al., 1992). Plcg2Ali5/+Rag1−/− mice de-
velop paw inflammation (Figure 6A), even with a higher
frequency than their Plcg2Ali5/+Rag1+/+ positive litter-
mates (70% versus 30%). As expected, Plcg2Ali5/+
Rag1−/− spleen did not contain follicular structures and
lacked B cells completely (Figure 6B, 3 and 4). The pri-
mary follicles of Plcg2Ali5/+Rag1+/+ contained less B
cells than the Plcg2+/+ Rag1+/+ wt spleen (Figure 6B, 3).
This shows that dermatitis and arthritis are not medi-
ated by, or dependent on, specific B or T cell popula-
tions. Autoreactive T cell responses or autoantibodies
seem not to be involved in the inflammatory paw phe-
notype induced by Plcg2Ali5. This suggests that non-B
non-T cells originating in the bone marrow expressing
the mutant Plcg2 allele are the inducer and effector
cells of the inflammatory pathology in vivo.
A Hyperreactive B Cell Phenotype Occurs in Both
C3HeB/FeJ and Hybrid C57BL/6J × C3HeB/FeJ
Mice, but Autoantibody Production and
Glomerulonephritis are Restricted to Hybrid Mice
Previous studies of Plcg2 in Plcg2-deficient mice high-
lighted its importance in acute responses and develop-
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458Figure 5. Innate Immune Cell Production in
Bone Marrow of Ali5 Mice and Transfer of the
Inflammatory Pathology to Wt Mice by Ali5
Bone Marrow Transfer
(A) Flow cytometric analysis of bone marrow
cells. Numbers indicate the percentage of
gated populations of lymphocytes. Top pan-
els show forward scatter (FSC) versus side
scatter (SSC) of bone marrow cells (BM). (R1)
contains lymphocytes and (R2) the larger
and more granular cells. The bottom panel
shows cells gated through R2. Macrophage-
CD11b+(Gr-1low/negative) and granulocyte-
CD11b+(Gr1high) precursors.
(B) Paw inflammation in a wt BL/6 mouse
transferred with bone marrow cells from an
Plcg2Ali5/Ali5 mouse (top photo) 4 weeks after
transfer and healthy paw in a mouse trans-
ferred with wt bone marrow (bottom photo).
(C) Indo-1 Ca2+ measurement of granulo-
cytes from peripheral blood of C3H mice.
Gr1-positive cells from heterozygous
Plcg2+/Ali5 (1) and wt mice (2) were stimu-
lated via the FcγR. Blood cells were loaded
with Indo-1 as described and activated in
Ca2+ containing buffer. Values are the ratio of
signal from Ca2+ bound Indo1(F6) to free
Indo-1 (F7).ment of B cells (Hashimoto et al., 2000; Wang et al., i
o2000). Analysis of Ali5 mice revealed a reduction in the
B2 cell population resulting in a higher T cell to mature m
hB cell (CD23+) ratio in blood (Figure 2A). A reduction of
mature B cells and transitional T2 B cells (Loder et al., n
B1999) below 30% of the wt numbers was found in in-
bred C3H Plcg2Ali5/+ and B6C3 hybrid Plcg2Ali5/Ali5
csplenocytes (Figure 7A).
Further FACS analysis between wt and mutant mice C
mrevealed that the decrease in B cells is at the expense
of the CD21int CD23hi follicular B cells (FB) in spleen k
2and leads to a relative increase in CD21hiCD23lo mar-
ginal zone (MZ) B cells (Oliver et al., 1999) (Figure 7A). P
TIn this context, it is notable that a fundamental strain
difference between wt C3H and BL/6 in spleen is that t
tC3H have a higher proportion of MZ B cells (30% ver-
sus 10%) but a lower percentage of total B cells (w35% f
iversus 55%) than B6 mice. In C3H mice, this leads to
the fact that about 60% of the B cells from Plcgγ2+/Ali5 a
Pmice display the MZ phenotype (see also Discussion).
In contrast to decreased B2 cells, but in line with the d
tproportional increase of MZ B cells in spleen, the dis-
tinct B1 population in the peritoneum is enlarged rather n
athen reduced by the effects of the mutated Plcg2Ali5
(Figure 7A). This does not lead to an absolute increase
cof B1 or MZ B cell numbers, because although the
number of peritoneal cells and splenocytes is compara- w
Dble between Ali5 and wt controls, the Ali5 mice containncreased numbers of larger and more granuled cells
utside the lymphocyte gate (data not shown). Further-
ore, the B1-MZ B cell populations are decreasing in
omozygous mice (Figure 7A), probably due to stronger
egative selection, which affects the relative-resistant
1-MZ subsets.
Serum immunoglobulin levels were not significantly
hanged, with the exception of increased IgM in male
3H Ali5 mice (Figure 7C). The response in vitro to the
itogens LPS, anti-CD40, and IL-4 plus anti-IgM,
nown to be dependent of PLCγ function (Wang et al.,
000), was higher for splenic B cells from inbred C3H
lcg2Ali5/+ mice than in wt counterparts (Figure 7B).
hese data show that the remaining mature B cells with
he mutated Plcg2Ali5 are hyperresponsive to B cell mi-
ogens and suggest that they are also hyperreactive to
urther BCR activation. To examine this hypothesis, we
mmunized the inbred mice and also examined auto-
ntibody production. Immunization of inbred C3H
lcg2Ali5/+ mice and control littermates with a T-depen-
ent antigen showed comparable levels of specific an-
ibodies for IgM and IgG1, despite the reduced B cell
umbers of Ali5 mice (Figure 7D). However, the IgG2a-
nd IgG3-specific antibodies were reduced in Ali5.
T-independent antibody responses were slightly in-
reased in C3H Ali5 mice (Figure 7D). This is consistent
ith a relative increase of MZ B cells in the spleen. Anti-
NA antibodies were not detected in Plcg2Ali5/+ mice
Mutant Plcγ2 Causes Autoimmunity and Inflammation
459Figure 6. Lymphocyte-Independent Inflammatory Pathology in
Rag1−/− Plcg2+/Ali5 Mice
(A) Inflammation score of Rag1-deficient C3H Plcg2+/Ali5 mice at
the age of 6–8 weeks. Macroscopically visible swollen, inflamed
footpads develop in Plcg2+/Ali5 on both the heterozygous and
Rag1-deficient background.
(B) Phenotypical analysis of Rag1-deficient C3H Plcg2+/Ali5 mice.
Panels in row 1 show histological analysis of an HE staining of an
inflamed footpad (320×) of a Rag1−/− Plcg2+/Ali5 mouse (left column)
and corresponding spleen sections (row 2; HE). Row 3 is immunhis-
tochemical staining with anti-B220 B cell marker on spleen sec-
tions (200×). The arrow indicates the position of the arteriole, where
exclusively granulocytes are observed. Rare B220-positive cells are
identified in the spleen (insert, 640×). Middle column shows a
Rag1+/+ Plcg2+/Ali5 mouse. There is severe inflammation of the skin
(320×). Note that Rag1+/+ Plcg2+/Ali5 mouse has lymphocyte follicles
in the spleen (100×) with a reduced number of B220/CD45R-posi-
tive B cells, when compared to the wt mouse (right). FACS analysis
of peripheral blood with anti-B220 (row 4) confirms absence of B
cells in Rag1−/− Plcg2+/Ali5 and reduced B cell numbers in Rag1+/+
Plcg2+/Ali5 compared to the wt mouse.on the inbred C3H background. However, 28% of
Plcg2Ali5/+ and 66% of Plcg2Ali5/Ali5 hybrid mice exhibit
high anti-DNA antibody titers of the IgG isotype (Figure
7E). Thus, there appears to be in vivo evidence for hy-
perresponsiveness of B cells. Further, Plcg2Ali5/+ and
Plcg2Ali5/Ali5 hybrid Ali5 mice develop glomerulonephri-
tis. The penetrance was 30% and 100% in Plcg2Ali5/+and Plcg2Ali5/Ali5 mice, respectively. This correlates with
the presence of autoantibodies and supports the notion
of autoimmunity resulting in glomerulonephritis due to
immune complex deposition in the kidney.
Discussion
In this study, we describe a gain-of–function mutation
in Plcg2 that is linked to signaling and functional dereg-
ulation of the immune system in vivo. Furthermore, the
analysis of mice with this mutation validates the ENU
approach to provide insights into mechanisms leading
to autoimmunity and inflammation (Vinuesa and Good-
now, 2004) as well as highlighting the importance of
complex genetic interactions in such disorders.
Within the signaling context of B cells, the mutation
in Plcg2Ali5 causes increased and sustained calcium re-
sponses with an influx of extracellular calcium as the
dominating component. Previous studies implicated
PLC in regulation of calcium influx by several mecha-
nisms (Putney, 2002; Putney et al., 2001). The best-doc-
umented mechanism involves PI-3K- and Btk-mediated
activation of Plcγ2 that results in IP3 production leading
to calcium influx into the cytoplasm from internal endo-
plasmatic reticulum stores and later through store-
operated channels (SOCs) of the plasma membrane.
Recently, in vitro experiments using the DT40 cell line
showed that PLCγ1 and PLCγ2 can control external
Ca2+ entry mediated by plasma membrane calcium
channels. Surprisingly, a lipase-deficient mutant, PLCγ,
was active, presumably functioning independently from
the secondary messengers it usually generates (Patter-
son et al., 2002). This lack of an absolute requirement
of PLCγ ’s catalytic function implies an additional direct
influence of PLCγ on the classical SOCs or store-deple-
tion-independent calcium channels (Putney, 2002).
Although the precise changes that underlie enhanced
calcium signals by Plcγ2Ali5 need to be elucidated fur-
ther, our data suggest the possibility that the Plcg2Ali5
mutation could involve several mechanisms. First, in-
creased stability and penetrability at the plasma mem-
brane could result in enhanced and sustained signal-
ing. The mutation is present at the surface region of
the catalytic domain that normally restricts membrane
interactions. Mutations in this region in PLCδ1 have
been reported to enhance such interactions (Ellis et al.,
1998). The amino acid change D993G removes a nega-
tive charge from a critical region of the molecule that
has to come into close proximity with the inner plasma
membrane, which is negatively charged. One possi-
bility might therefore be a reduced repulsion of the mu-
tated Plcγ2. As a consequence, this would result in the
increase in membrane stability of Plcγ2Ali5 that we ob-
served. This could mimic the stabilization normally pro-
vided by PIP3. It is well documented that PIP3 interacts
with the PH domain of Plcg2 to target it to the mem-
brane and therefore allows sustained Ca2+ flux (Schar-
enberg and Kinet, 1998). One way to regulate Plcγ2
function seems to be degradation of PIP3 by the phos-
phatase activity of SHIP, resulting in release of Plcγ2
from the membrane and termination of the Ca2+ signal.
Because SHIP is recruited by the inhibitory FcγRIIb (Ra-
vetch and Bolland, 2001; Scharenberg and Kinet, 1998),
Immunity
460Figure 7. B Cell Phenotype and Function in
Plcg2Ali5 Mice
(A) In the top panels, the staining with anti-
CD43 versus anti-B220 of peritoneal lym-
phocytes (10,000 cells in the lymphocyte
gate) defines B1 cells (CD43+B220+) and B2
cells (CD43−B220+). Middle panels show
analysis of B cell populations in spleen
(w19,000 cells in the lymphocyte gate) by
anti-IgM/anti-IgD staining. The gates corre-
spond to mature (M), transitional 1 (T1) and
transitional 2 (T2) B cells. Bottom panels
show CD21hiCD23lo marginal zone (MZ) B
cells and CD21int CD23hi follicular B cells
(FB). Numbers are a percentage of gated
cells; in brackets are cell numbers.
(B) Proliferation assay with B220+-purified B
cells of inbred C3H Plcg2+/Ali5 and wt litter-
mates. 3H-thymidine incorporation of cells
stimulated with the depicted stimuli. Differ-
ences marked with an asterisk are statistic-
ally significant (p < 0.01). Error bars repre-
sent the SD for n = 4 mice per group.
(C) Serum immunoglobulin levels for male
and female C3H inbred Plcg2+/Ali5 and wt lit-
termates. IgM, IgG isotypes, and rheumafac-
tor (anti-IgG Ab, RHF) are depicted. Error
bars represent the SD for n = 6 mice per
group.
(D) Immunization of C3H-inbred Plcg2+/Ali5
and wt littermates with the T-dependent anti-
gen ovalbumin and T-independent antigen
pneumococcal polysaccharide.
(E) Serum levels of anti-DNA IgG autoanti-
bodies.
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461the marked increase in Ca2+ flux in cells from Plcg2Ali5
mice when a FcγRIIb-engaging complete Ab is used for
BCR stimulation argues for an independency of
Plcγ2Ali5 from PIP3-dependent membrane localization.
As a consequence, the enzyme could have prolonged
access to its substrate. The similarity of the Km values
of recombinant wt and Ali5 mutant Plcg2 protein further
supports a more general role in the membrane interac-
tions rather than substrate recognition.
Second, the other possibility is that not all Ca2+ re-
sponses could be attributed to the differences in en-
zyme activity in cells and IP3 production. The mutation
might positively affect the functional juxtaposition of a
postulated signaling complex containing the adaptors
(Grb2/NTAL/SLP-65), Btk, Plcγ2, and an unknown cal-
cium channel (Putney, 2002; Stork et al., 2004). This
could lead to the observed specific difference in Ca2+
channel-mediated external Ca2+ influx without the in-
volvement of Plcγ2’s lipase activity. The importance of
this protein-protein interaction in controlling Ca2+ entry
has recently been demonstrated by PLCγ1 directly reg-
ulating the TRPC3 Ca2+ channel via a novel partial PH
domain interaction (van Rossum et al., 2005).
Inhibition of the mutant Plcγ2Ali5 using the pharmaco-
logical agent U73122 is difficult to interpret but never-
theless important. First, we show that the PLC inhibitor
U73122 is able to almost completely block PLC activity
in both heterozygous and homozygous mutant B cells,
thus demonstrating that the mutant protein is sensitive
to a known PLC inhibitor and that PLC activity is essen-
tial for the enhanced response observed in mutant
cells. Second, it is known that the PLC-specific inhibi-
tor U73122 may also have additional inhibitory effects
on certain Ca2+ channels (Taylor and Broad, 1998),
which could be direct targets for Plcγ2.
It has been shown that mutations in the BCR signal-
ing pathway resulting in stronger BCR signals and ele-
vated Ca2+ responses have an impact on B cell devel-
opment (Marshall et al., 2000). By analogy, the effect of
the Plcg2Ali5 mutation in B cells can be explained in
terms of altered negative and positive selection acting
on emerging B cells. Mutant mice with a reduced num-
ber of mature B cells that are hyperresponsive to vari-
ous B cell signals have been described (Marshall et al.,
2000). In such circumstances, an increased signal
strength through the BCR during negative selection re-
sults in a reduced threshold for deletion of mature B2
cells after the T1 stage (Loder et al., 1999), resulting in
less mature B cells, similar to the situation in Ali5 mice.
However, the B1 cell lineage, and to some extent MZ B
cells, seem to be less sensitive to negative selection
processes and are not deleted but expand during posi-
tive selection (Berland and Wortis, 2002), providing an
explanation for the relative increase of these cells in
Ali5 mice.
The surprising finding of an increased proliferative re-
sponse to a toll-like receptor ligand, LPS, and a CD40
signal in Plcg2Ali5 mice has two possible nonexclusive
explanations. First, ligand-indepedent tonic signaling
from the BCR could lead to a synergistic activation sig-
nal in vivo and in vitro (Monroe, 2004). Second, it has
been reported that MZ B cells respond with increased
proliferative response to LPS and anti-CD40 compared
to FB cells (B2 B cells) (Oliver et al., 1999). The propor-tional increase of MZ B cells in C3H Ali5 mice may be
reflected in an increased proliferation of B220+ splenic
B cells. It is particularly interesting that our results sug-
gest that signaling via Plcγ2 does have an indirect ef-
fect on both LPS and CD40 signaling, probably by af-
fecting B cell lineage selection, although neither of
these ligands is known to directly activate Plcγ2. Analo-
gous conclusions can be drawn from impaired prolifer-
ative responses of splenic B cells of Plcγ2-deficient
mice (Wang et al., 2000).
There are several ways that these B cell changes
could lead to a breakdown in tolerance. First, the re-
maining mature B cells respond with an elevated re-
sponse to BCR signals. If a mature B cell escapes
negative selection and is still able to recognize self-
antigen, the response would be increased, leading to B
cell expansion and production of autoantibodies. This
is reflected in Ali5 mice in a relatively strong specific
antibody response and induction of autoantibody pro-
duction that ultimately leads to immune complex glo-
merulonephritis in the B6C3 background. Second, the
remaining numbers of MZ B cells and B1 cells might be
responsible. B1 cells have been associated with self-
reactivity (Berland and Wortis, 2002). B1 cells produce
primarily IgM, and levels were higher in Ali5 male mice
on the C3H background compared to wt controls. Re-
gardless of the cell type responsible, it is still surprising
how a single mutation in Plcg2 can break the mecha-
nisms regulating self-tolerance (Halverson et al., 2004).
Although there is evidence that clonal deletion operates
in bone marrow and spleen of Ali5 mice, other periph-
eral mechanisms of B cell tolerance like anergy or re-
ceptor editing await analysis.
The cell phenotype in Ali5 mice is consistent with a
gain-of-function mutation in Plcg2 and is supported by
the previously reported immunological phenotype in
Plcg2-deficient mice, which is diametrically opposed to
Ali5. Ca2+ mobilization is completely lacking in B cells
after BCR activation, the proliferative response to in vi-
tro B cell stimulation is reduced, B1 cells are absent
from the peritoneum, and they fail to respond to T-inde-
pendent antigens (Hashimoto et al., 2000; Kurosaki et
al., 2000; Marshall et al., 2000; Wang et al., 2000). The
Ali5 phenotype, particularly the duality of inflammation
and B cell autoimmunity, displays striking similarities
with the mouse mutants of the tyrosine kinase Lyn and
the phosphatase Shp-1 (Me/Mev) (Hibbs et al., 2002;
Shultz et al., 1997). Both molecules regulate Plcγ2, and
mutant B cells respond with enhanced Ca2+ signaling.
Although the restricted expression of Lyn to B cells
might limit the disease phenotype to immune complex
glomerulonephritis, lethal inflammation and autoanti-
body production are also present in Me/Mev mice,
probably because of the loss of the even wider inhibi-
tory function of Shp-1 in macrophages and granulo-
cytes. An additional similarity is the complete lympho-
cyte independency of the inflammation in both Plcg2Ali5
and Shp-1Me/Mev mice (Yu et al., 1996). The Ali5 pheno-
type suggests that Plcγ2 is an important downstream
molecule in Lyn gain-of-function and Shp-1Me/Mev-
driven disease.
Although the role of Plcγ2 is comparably well under-
stood in B cells, the understanding of its function and
integration in signaling pathways of other cells is lim-
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462ited. Plcg2 is primarily expressed in haematopoietic a
cells (Wang et al., 2000). The dermatitis and arthritis in i
Ali5 mice are independent of B and T cells but depen-
dent on a transferable bone marrow-derived haemato- c
poietic cell population. The transfer of bone marrow 2
from a Plcg2Ali5/Ali5 homozygous mouse, which consists C
mainly of macrophage/granulocyte precursors, leads to i
paw inflammation evident within 4 weeks of transfer. P
Plcg2 is expressed in mast cells and monocytes/
macrophages and is activated by crosslinking of FcRI a
and activating Fcγ receptors, resulting in an elevation c
in intracellular Ca2+ levels. Plcg2-deficient mice have g
normal numbers of these cells, but FcRI- and FcγR- t
mediated processes, such as FcγR-mediated phagocy- f
tosis in macrophages and FcγR-mediated passive skin g
inflammation induced by mast cells, are impaired (Wen v
et al., 2002). Given this, it seems possible that lowering N
of the threshold for an activation signal in these cells i
could result in the acquisition of autoreactive behavior. g
Certainly, the triggering of tissue-specific inflammation d
seems to involve an increased production of granulo- h
cytes/macrophages cells in Plcg2Ali5 mice, which could g
depend on increased M-CSF receptor signaling (Bou- m
rette et al., 1997). The proof that granulocytes also re-
spond with increased Ca2+ flux to FcγR stimulation im- s
plies that a pathway, involving Plcγ2, exists that drives i
and/or directs these cells during inflammation. How- t
ever, the exact nature of the stimulus that targets the i
inflammation to restricted areas of the body remains to p
be determined together with the exact role of implied s
signaling pathways (FcγR, M-CSF R, and FcRI) that re- d
cruit Plcγ2 in these cells in an autoimmune-inflamma- m
tory process. Failure to trigger an enhanced response i
of inflammatory cells from Ali5 mice in vitro by various i
microbial toll-like receptor ligands and in vivo by two n
inflammatory stimuli underlines the enigmatic nature of i
the initial trigger that leads to specific autoaggressive a
reactions. i
One of the commonly accepted theories of autoim-
munity focuses on the function of autoreactive helper E
T cells, which might drive the disease by induction of
organ-specific inflammatory processes (Khoury and E
ESayegh, 2004; Mathis and Benoist, 2004). The K/BxN-
vTCR-transgenic mouse model and a mouse mutant
fwith a point mutation in the signaling molecule ZAP-70
o
both develop symptoms similar to rheumatoid arthritis 6
in humans (Korganow et al., 1999; Sakaguchi et al., a
2003), pointing to autoreactive T cells as the initial trig- t
Pger for the autoimmune process. The Lyn, Shp-1, and
bparticularly Ali5 mutants contrast with this model. The
Pmechanism leading to both inflammatory disease and
lB cell-mediated autoimmunity in the Ali5 mouse must
t
be different, because Plcg2 appears not to be involved
in T cell function (Emori et al., 1989; Wilde and Watson, I
2001), and the paw inflammation occurs in the absence T
of B or T cells. It might involve a direct activation of l
B cells (Martin and Chan, 2004) and haematopoietic w
bnon-B, non-T cells.
eFunctional experiments with samples from patients
Nwill be necessary to examine if similar signaling path-
w
ways might be engaged in human disease. The Ali5 s
phenotype seems not to be directly comparable to a r
single human illness such as WG, rheumatoid arthritis, f
mor SLE (Martin and Chan, 2004), and genetic linkagenalysis has yet to reveal an association of PLCG2 or
ts signaling pathway with these diseases.
Nevertheless, in particular, human SLE might share a
ommon mechanism of B cell hyperactivity (Lipsky,
001) and diagnostic criteria as dermatitis, increased
a2+ mobilization in B cells (Liossis et al., 1996) and
mmune complex glomerulonephritis with the murine
lcg2Ali5 phenotype.
Another similarity between the Plcg2Ali5 phenotype
nd the human situation is the complex genetics, be-
ause unexpectedly, a change in the genetic back-
round from C3H to hybrid C3B6 dramatically altered
he pathology in heterozygous Ali5 mice. The change
rom inflammation to B cell autoimmunity in the mixed
enetic background is accompanied by regaining of in
itro-fertilizing capacity of sperm and male fertility (P.Y.,
.D., U.H., S.K., L.Q.-M., unpublished data). Thus, mod-
fier genes must exist in the different genetic back-
rounds that are able to differentially control Plcg2Ali5-
riven disease. Additionally, the phenotype of the
omozygous mice on the different genetic back-
rounds implies a gene-dosage effect of the Plcg2Ali5
utant allele that can overcome the effect of modifiers.
In conclusion, we provide evidence that an enhanced
ignal in vivo by a member of the phospholipase C fam-
ly of signaling molecules leads to severe pathology
hat is similar to a variety of human inflammatory-auto-
mmune diseases. Thus, an autoimmune-inflammatory
athology can be induced by a single mutation in a key
ignaling molecule that targets external Ca2+ influx. Ad-
itionally, other, as yet unknown, genes can extensively
odulate the severity of the induced disease. Our find-
ngs indicate that mutations in loci of the genes encod-
ng signaling molecules in B cells and haematopoietic
on-B, non-T cells also contribute to autoimmunity and
nflammation. This mouse model will enable further
nalysis of the role of Plcg2 and its genetic modifiers
n complex genetic inflammatory-autoimmune diseases.
xperimental Procedures
NU Mutagenesis and Mice
NU mutagenesis of C3HeB/FeJ male mice was performed as pre-
iously described (Hrabe de Angelis et al., 2000). C3H Ali5-affected
emale mice were mated to C3H wt males, and the heterozygous
ffspring were used for analysis. In addition, crossing to C57BL/
J wt male mice was performed for positional cloning and further
nalysis. Rag1-deficient mice on the C3H background were ob-
ained from I. Förster, TUM, and used for mating with C3H inbred
lcg2Ali5/+ mice. The phenotype was confirmed by FACS. In the
one marrow transfer, 1.5 × 106 cells from a hybrid B6C3
lcg2Ali5/Ali5 mouse were injected i.v. into wt recipients, which were
ethally irradiated by a split dose of 2 × 500 Gray and treated with
he antibiotic Polymyxin B (Sigma).
dentification of the Mutation by Positional Cloning
o map the mutation, an outcross and backcross strategy was fol-
owed. Female C3HeB/FeJ mice demonstrating the Ali5 phenotype
ere outcrossed to C57BL6/J, and the resulting N1 hybrids were
ackcrossed again to C57BL6/J. For chromosomal localization,
qual amounts of DNA extracted from tail biopsies of 12 unaffected
2 mice were pooled. The allele frequency of this pooled sample
as determined for 90 equally spaced genome wide-distributed
ingle-nucleotide polymorphic (SNP) markers by using a Luc96 py-
osequencer (Pyrosequencing AB). After this initial mapping, unaf-
ected and affected mice were typed individually to confirm the
ap location and narrow down the region by the analysis of single
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463recombination events. As the ratio of T cell versus mature B cells
is a fully penetrant phenotype in N1 and N2 animals, in contrast to
the paw phenotype, recombination events in affected and unaf-
fected animals could be used for mapping. The fine mapping was
based on 422 meiotic events and finally reduced the locus to 1.3
Mb between the microsatellite markers D8Ing65 (PCR primer
D8Ing65-F, 5#-GCCTCAGCCTACTCTGAC-3# and PCR primer
D8Ing65-R, 5#-CTGACGTCAATGTTACCATG-3#) and D8Ing60 (PCR
primer D8Ing60-F, 5#-GCTAAGATACAGGCATGGTTCG-3# and PCR
primer D8Ing60-R, 5#-TTCCAGGAGGTGGAAAGAAGAG-3#). Sev-
eral candidate genes, including Plcg2, in the region were se-
quenced at the genomic and cDNA levels. The genomic structure
of Plcg2 (33 exons) was deduced from known spliced mouse ESTs,
public rat (NM_017168), and human (XM_051778; NM_002661)
PLCG2.
Plcg2Ali5 Gene Expression
RNA expression of CD45R/B220-positive B cells (purified by MACS
Miltenyi, Germany) was examined in a pool of ten inbred C3HeB/
FeJ Plcg2Ali5/+ and five Plcg2+/+ littermate mice. Expression of
Plcg2 and four dysregulated genes were tested by light cycler
quantitative PCR (Boehringer). The primers for Plcg2 were: A: 5#-
CCTTTACGACACGCACCAG-3#, B: 5#-CACGGTGTTCACGAGCGC-
3#; S100A9, A: 5#-GTTGGGCAGCAGTCACATGG-3#, B: 5#-CAG
ACAAATGGTGGAAGCACAG;S100A6-3#; A: 5#-CCCTGAGCAAG
AAGGAGCTG-3#, B: 5#-GGAAGTCATCTCAACGGTCC-3#; MEK1
(Map2k), A: 5#-GAAGCAGCTCATGGTACATGC-3#, B: 5#-GCAACA
TGGCATGCCACTGGG-3#; Iga, A: 5#-GTCAGTCATGGCTTTTCCAGC-
3#, B: 5#-GCAGTGGTGCCAGGGACGCTG-3#; and Housekeeping
gene b2microglobulin, A: 5#-CCTCACATTGAAATCCAAATGCTGA-
3#, B: 5#-TCTTGGGCTCGGCCATACT-3#; the B cell-specific gene
Cd19 primers A: 5#-CAGCATGGGAAGGAGAGG-3#, B: 5#-GCT
TTGCTTGAACATGCATATG-3#, and C: 5#-GCTTCAGAGAATTTGAG
TGGC-3# were used as standards. Western blots for Plcγ2 detec-
tion were done by standard procedure using a goat anti-Plcγ2 se-
rum (Santa Cruz).
Histology, Immunohistochemistry, X-Ray Analysis,
and Electron Microscopy
Organs were fixed in 4% (w/v) formaldehyde. Paraffin-embedded
tissue sections (3 m) were stained with haematoxylin and eosin
and with giemsa or PAS where indicated. Bones were decalcified
in EDTA for at least 6 weeks. Paraffin-embedded spleen sections
were analyzed for expression of B220/CD45R (BD Pharmingen,
Heidelberg, Germany) by using an automated immunostainer (Ven-
tana Medical Systems, Strasbourg Cedex, France) per the manu-
facturer’s protocol. Animals were analyzed by X-ray (Faxitron Cabi-
net X-Ray System) in order to document the presence of bone
changes. Kidney tissue was fixed in 3% (w/v) glutaraldehyde and
examined by transmission electron microscopy.
Flow Cytometry and Calcium Fluorimetry
Cells were stained with combinations of anti-IgD, anti-IgM, anti-
CD45R/B220, anti-CD3, anti-CD43, anti-CD23, anti-CD11b, and
anti-Gr-1 (Ly6G). Monoclonal antibodies conjugated to fluorescein
isothiocyanate, phycoerythrin (PE), or allophycocyanin (APC) were
obtained from Pharmingen. Analysis was done on a FACScalibur
(Becton Dickinson) and a Cyan (Dako Cytomation). Calcium moni-
toring was done in spleen cells at 2 × 106 cells in a volume 400 l.
They were loaded with 2 M Fluo-3, Fura-Red, or 10 M Indo-1
(Molecular Probes) in HBSS buffer for 40 min at room temperature
and stained with anti-B220-APC. For T cell activation, loaded cells
were stained at 4°C with anti-CD90-PE and rat-anti-TCRβ (H57-
597) at a concentration of 10 g/ml. Calcium fluorescence was de-
termined in B220- or CD90-positive cells by flow cytometry. B cells
were stimulated by 15 g goat anti-IgM (Star86, Serotech) antibody
or 19.5 g goat anti-IgM F(ab)2 fragment (Jackson ImmunoRe-
search). Inhibition of Ca2+ flux was done at 0.2 M concentration
of U73122 (Biomol) for 5 min at 37°C. Peripheral blood cells were
stained with Ly6G anti-Gr1 and Fc Block (2.4G2, Becton Dickinson)
and crosslinked by anti-rat IgG (Southern Biotech) as described
(Wen et al., 2002). T cells were stimulated by adding 15 g rabbit
anti-rat IgG Ab (Pharmingen). Analysis was done with FlowJo soft-ware. In vitro Ca2+ mobilization was performed with primary splenic
B cells stimulated for 24 hr with 10 g/ml LPS. Cells were infected
in vitro by Plcg2 wt and mutant cDNA cloned into the MSCV2.2-
derived Vector MIGR1 (Pear et al., 1998). Ca2+ analysis was done
48 hr after infection. For stimulation experiments without free Ca2+,
HBSS without Ca2+ was used and 3 mM EGTA was added. Thapsi-
gargin (Sigma) was used at a final concentration of 1 M.
Proliferation Assay
B220+ splenocytes were positively enriched by MACS according to
the manufacturer’s guidelines (Miltenyi Biotec). and resulted in
70%–80% purity from C3H Ali5 mice (n = 8) and 90% purity from
wt littermates (n = 5). For proliferation assays, 2 × 105 cells per
well in flat-bottom 96-well plates were incubated with the following
stimuli: LPS (20 g/ml, Sigma), IL-4 (40 ng/ml, Preprotech), anti-
IgM F(ab)2 (2 g/ml, Jackson ImmunoResearch), and anti-CD40 (1
g/ml, Pharmingen). Incubation was for 72 hr with the last 14 hr
pulsed with 1 Ci/well 3H-dT (Pharmacia).
Immunization and ELISAs
Isotype-specific serum immunoglobulin levels were determined by
standard ELISA. Rheuma factor (RHF) antibodies were detected by
coating of ELISA plates with mouse IgG1/ lambda light chain Ab
(Becton Dickinson). Bound anti-IgG RHF was detected by biotin-
ylated anti-kappa light chain Ab (Dianova).
C3H Plcg2+/Ali5 mice and wt littermate controls 6–8 weeks of age
were immunized either intraperitoneally or subcutaneously and
boosted 3 weeks later with a total of 100 g chicken ovalbumin
adsorbed to Alum (Fluka). Blood was taken 6 days later, and the
serum was separated and used for specific ELISAs. Similarly, spe-
cific T-independent responses were measured at day 7 after a sin-
gle intraperitoneal injection of 10 g pneumococcal polysaccharide
type 19 (American Type Tissue Collection). The values given are
specific dilutions at half-maximal optical density. Detection of anti-
DNA autoantibodies was performed as described earlier (Flaswin-
kel et al., 2000). The mice were C3H Plcg2Ali5/+ mice (n = 13,
average age 102 days), Plcg2+/+ (n = 13, average age 91 days),
hybrid N1 or N2 hybrid Plcg2Ali5/Ali5 (n = 12, average age 133 days),
Plcg2Ali5/+ (n = 25, average age 113 days), and wt Plcg2+/+ (n = 12,
average age 123 days). The values given are specific dilutions at
half maximal optical density compared to a standard serum of lpr
mice.
In Vitro PLC Assay and Localization
of Membrane-Associated Plc2
The recombinant proteins were full-length Plcg2-His6 constructs of
wt and mutated enzyme expressed by using baculovirus as de-
scribed previously (Rodriguez et al., 2001). The preparations were
used for measurements of PLC activity by using detergent-mixed
micelles containing sodium cholate and 3H-PIP2 (Ellis et al., 1998).
Plcγ2 membrane localization studies were done as described
previously (Rodriguez et al., 2001). Briefly, cells were homogenized
in hypotonic lysis buffer, and after removal of nuclei by centrifuga-
tion, supernatants were subjected to further centrifugation at
100,000 × g for 30 min. The precipitates were resuspended in lysis
buffer containing 1% Triton X-100 and subjected to centrifugation
at 12,000 × g for 20 min, and the resulting supernatants represent-
ing particulate/membrane fraction analyzed by Western blotting.
Anti-Calveolin-1 Ab and total Plcγ2 detection were used as mem-
brane and loading control respectively.
Plcg2Ali5 Homology Structural Model
The homology model for the X and Y domains of Plcγ2 (Figure 3A)
was made with the MOE program and based on the crystal struc-
ture of Plcδ1 (Essen et al., 1996). The figure was generated with the
molecular modeling program package SYBYL (Tripos Associates,
USA).
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